Lumena Pharmaceuticals
Latest round
- Series B
Last raised
- Mar 2014
Total raised
- $75M
Investors
- 6
About Lumena Pharmaceuticals
Founded in 2011, Lumena Pharmaceuticals operates out of San Diego, US, and specializes in the development of pharmaceutical solutions. The company underwent a significant transition when it was acquired by Shire PLC for USD 260 mn on May 12, 2014.Lumena Pharmaceuticals specializes in innovative biomedical design, focusing on enhancing human health and longevity. Their core product offerings encompass a diverse range of pharmaceuticals, nutraceuticals, and contract research and development services. The company aims to address critical gaps in modern medicine by delivering tailored solutions that cater to the evolving needs of the home health market. Their client base includes healthcare providers and industry partners across North America, Europe, and Asia, with an emphasis on empowering end users through accessible and effective health products.Lumena Pharmaceuticals operates on a business-to-business and direct-to-consumer transactional model, engaging with clients through strategic partnerships and distribution agreements. Revenue streams may include subscriptions for ongoing product supply, alongside direct sales to healthcare providers and retail outlets. Clients may enter contracts for both individual products and comprehensive service packages, including private label services and generics, ensuring a flexible approach to meet varied market demands. Flagship products are positioned at competitive price points, reflecting their innovative design and efficacy, allowing the company to establish a solid foothold in diverse geographical markets.Following the acquisition by Shire PLC, Lumena Pharmaceuticals is expected to leverage its resources to enhance its product pipeline and market reach. The company has plans to launch new products in the near future, although specific release dates have not been disclosed. Lumena Pharmaceuticals aims to expand into new markets in Europe and Asia within the next two years, utilizing the USD 260 mn from its recent acquisition to support these initiatives and further develop its innovative offerings.
Who invested in Lumena Pharmaceuticals
6 investors across 5 rounds
See all investors in Lumena Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Lumena Pharmaceuticals
Who invested in Lumena Pharmaceuticals?
Lumena Pharmaceuticals has 6 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Lumena Pharmaceuticals raised?
Lumena Pharmaceuticals has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Lumena Pharmaceuticals last raise money?
Lumena Pharmaceuticals's most recent round on record is a Series B, in Mar 2014.
What does Lumena Pharmaceuticals do?
Founded in 2011, Lumena Pharmaceuticals operates out of San Diego, US, and specializes in the development of pharmaceutical solutions.
Where is Lumena Pharmaceuticals headquartered?
Lumena Pharmaceuticals is headquartered in San Diego, US.
Which VCs invest in companies like Lumena Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Lumena Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Lumena Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.